BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/24/2022 10:35:19 AM | Browse: 754 | Download: 1787
 |
Received |
|
2021-12-09 17:56 |
|
Peer-Review Started |
|
2021-12-09 17:59 |
|
First Decision by Editorial Office Director |
|
2022-02-15 00:15 |
|
Return for Revision |
|
2022-02-15 00:15 |
|
Revised |
|
2022-02-28 17:46 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-04-08 02:16 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-04-09 19:07 |
|
Articles in Press |
|
2022-04-09 19:07 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-05-07 02:22 |
|
Publish the Manuscript Online |
|
2022-05-24 10:35 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nicole Cianci, Mohsan Subhani, Trevor Hill, Amardeep Khanna, Dong Zheng, Abhishek Sheth, Colin Crooks and Guruprasad P Aithal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nicole Cianci, MBBS, Academic Fellow, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust and University of Oxford, NA, Oxford OX3 9DU, United Kingdom. nicolecianci95@gmail.com |
| Key Words |
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Biomarkers; Non-invasive; Prognosis; Mortality |
| Core Tip |
Non-alcoholic fatty liver disease (NAFLD) represents a growing public health concern, with an estimated prevalence in European general populations of 20%-40% and epidemiological projections of significant future increase in prevalence. NAFLD patients are at increased risk of morbidity and mortality, so it’s important to validate non-invasive prognostic markers for predicting mortality in NAFLD. This systematic review highlighted several non-invasive prognostic markers including biomarkers and imaging modalities. This meta-analysis showed that NAFLD fibrosis score is a useful prognostic marker for all-cause and cardiovascular mortality, which can be implemented in clinical practice to risk stratify and target high risk NAFLD patients. |
| Publish Date |
2022-05-24 10:35 |
| Citation |
Cianci N, Subhani M, Hill T, Khanna A, Zheng D, Sheth A, Crooks C, Aithal GP. Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis. World J Hepatol 2022; 14(5): 1025-1037
|
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i5/1025.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i5.1025 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
